Manali I Patel1, Clayton W Schupp, Scarlett L Gomez, Ellen T Chang, Heather A Wakelee. 1. Manali I. Patel, Scarlett L. Gomez, Ellen T. Chang, and Heather A. Wakelee, Stanford University; Scarlett L. Gomez and Heather A. Wakelee, Stanford Cancer Institute, Stanford; Clayton W. Schupp and Scarlett L. Gomez, Cancer Prevention Institute of California, Fremont; and Ellen T. Chang, Exponent Health Sciences Practices, Menlo Park, CA.
Abstract
PURPOSE: Hispanics in the United States have lower age-adjusted mortality resulting from non-small-cell lung cancer (NSCLC) compared with non-Hispanic whites (NHWs). The purpose of this study was to evaluate individual, clinical, and neighborhood factors in survival among Hispanics with NSCLC. PATIENTS AND METHODS: We performed a retrospective analysis of NHWs and Hispanics with NSCLC between 1998 and 2007 in the California Cancer Registry (follow-up to December 2009). Kaplan-Meier curves depict survival by nativity for Hispanics with NSCLC. Cox proportional hazards models estimated hazard of mortality by race with adjustment for individual (age, sex, marital status), clinical (histologic grade, surgery, irradiation, chemotherapy), and neighborhood factors (neighborhood socioeconomic status, ethnic enclave). RESULTS: We included 14,280 Hispanic patients with NSCLC. Foreign-born Hispanics had 15% decreased risk of disease-specific mortality resulting from NSCLC compared with NHWs (hazard ratio [HR], 0.85; 95% CI, 0.83 to 0.88) after adjustment for individual, clinical, and neighborhood factors. After adjustment for individual factors, compared with US-born Hispanics, foreign-born Hispanics had 10% decreased risk of disease-specific mortality (HR, 0.90; 95% CI, 0.87 to 0.96). Clinical and neighborhood factors slightly moderated the survival benefit for foreign-born patients. A modestly more pronounced survival advantage was seen for foreign-born Hispanics living in low socioeconomic and high Hispanic enclave neighborhoods as compared with US-born Hispanics (HR, 0.86; 95% CI, 0.81 to 0.90). CONCLUSION: Foreign-born Hispanics with NSCLC have a decreased risk of disease-specific mortality compared with NHWs and US-born Hispanics with NSCLC. Neighborhood factors slightly moderate this survival advantage. This survival advantage is slightly more pronounced in lower socioeconomic and higher Hispanic enclave neighborhoods.
PURPOSE: Hispanics in the United States have lower age-adjusted mortality resulting from non-small-cell lung cancer (NSCLC) compared with non-Hispanic whites (NHWs). The purpose of this study was to evaluate individual, clinical, and neighborhood factors in survival among Hispanics with NSCLC. PATIENTS AND METHODS: We performed a retrospective analysis of NHWs and Hispanics with NSCLC between 1998 and 2007 in the California Cancer Registry (follow-up to December 2009). Kaplan-Meier curves depict survival by nativity for Hispanics with NSCLC. Cox proportional hazards models estimated hazard of mortality by race with adjustment for individual (age, sex, marital status), clinical (histologic grade, surgery, irradiation, chemotherapy), and neighborhood factors (neighborhood socioeconomic status, ethnic enclave). RESULTS: We included 14,280 Hispanic patients with NSCLC. Foreign-born Hispanics had 15% decreased risk of disease-specific mortality resulting from NSCLC compared with NHWs (hazard ratio [HR], 0.85; 95% CI, 0.83 to 0.88) after adjustment for individual, clinical, and neighborhood factors. After adjustment for individual factors, compared with US-born Hispanics, foreign-born Hispanics had 10% decreased risk of disease-specific mortality (HR, 0.90; 95% CI, 0.87 to 0.96). Clinical and neighborhood factors slightly moderated the survival benefit for foreign-born patients. A modestly more pronounced survival advantage was seen for foreign-born Hispanics living in low socioeconomic and high Hispanic enclave neighborhoods as compared with US-born Hispanics (HR, 0.86; 95% CI, 0.81 to 0.90). CONCLUSION: Foreign-born Hispanics with NSCLC have a decreased risk of disease-specific mortality compared with NHWs and US-born Hispanics with NSCLC. Neighborhood factors slightly moderate this survival advantage. This survival advantage is slightly more pronounced in lower socioeconomic and higher Hispanic enclave neighborhoods.
Authors: Theresa H M Keegan; Esther M John; Kari M Fish; Theresa Alfaro-Velcamp; Christina A Clarke; Scarlett L Gomez Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-05 Impact factor: 4.254
Authors: Limin X Clegg; Marsha E Reichman; Benjamin F Hankey; Barry A Miller; Yi D Lin; Norman J Johnson; Stephen M Schwartz; Leslie Bernstein; Vivien W Chen; Marc T Goodman; Scarlett L Gomez; John J Graff; Charles F Lynch; Charles C Lin; Brenda K Edwards Journal: Cancer Causes Control Date: 2007-01-11 Impact factor: 2.506
Authors: Michael J Thun; Lindsay M Hannan; Lucile L Adams-Campbell; Paolo Boffetta; Julie E Buring; Diane Feskanich; W Dana Flanders; Sun Ha Jee; Kota Katanoda; Laurence N Kolonel; I-Min Lee; Tomomi Marugame; Julie R Palmer; Elio Riboli; Tomotaka Sobue; Erika Avila-Tang; Lynne R Wilkens; Jon M Samet Journal: PLoS Med Date: 2008-09-09 Impact factor: 11.069
Authors: Niharika Dixit; Gregory B Crawford; Manon Lemonde; Cynthia N Rittenberg; Paz Fernández-Ortega Journal: Support Care Cancer Date: 2016-04-06 Impact factor: 3.603
Authors: Scarlett Lin Gomez; Salma Shariff-Marco; Mindy DeRouen; Theresa H M Keegan; Irene H Yen; Mahasin Mujahid; William A Satariano; Sally L Glaser Journal: Cancer Date: 2015-04-06 Impact factor: 6.860
Authors: Iona Cheng; Salma Shariff-Marco; Jocelyn Koo; Kristine R Monroe; Juan Yang; Esther M John; Allison W Kurian; Marilyn L Kwan; Brian E Henderson; Leslie Bernstein; Yani Lu; Richard Sposto; Cheryl Vigen; Anna H Wu; Scarlett Lin Gomez; Theresa H M Keegan Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-06-10 Impact factor: 4.254
Authors: Hubert Y Pan; Gary V Walker; Stephen R Grant; Pamela K Allen; Jing Jiang; B Ashleigh Guadagnolo; Benjamin D Smith; Matthew Koshy; Chad G Rusthoven; Usama Mahmood Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-02-09 Impact factor: 4.254
Authors: Alem A Belachew; Monica E Reyes; Yuanqing Ye; Gottumukkala S Raju; M Alma Rodriguez; Xifeng Wu; Michelle A T Hildebrandt Journal: Qual Life Res Date: 2020-07-03 Impact factor: 4.147
Authors: Antoinette M Stroup; Kimberly A Herget; Heidi A Hanson; Diana Lane Reed; Jared T Butler; Kevin A Henry; C Janna Harrell; Carol Sweeney; Ken R Smith Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-09-21 Impact factor: 4.254